Lab Study of MQX-503 in Treatment of Raynaud's

Clinical trial NCT00253331 · COMPLETED

Trial details

NCT number: NCT00253331
Sponsor: MediQuest Therapeutics
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Raynaud Disease Raynaud Disease Secondary to Scleroderma Raynaud Secondary to Other Autoimmune Disease

Start date: 2004-11-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.